Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD + metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP + and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NMN and NR demonstrated protect against diabetes, Alzheimer disease, endothelial dysfunction, and inflammation.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In hyperglycaemic mice, nicotinamide riboside administration improved liver steatosis and glucose tolerance, and reduced weight gain257.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [257]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The natural source of oral NR, NAM and NA is largely the NAD+ in the food we eat as broken down by digestion and the microbiome23.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
NAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationBogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Self-citation
Cited by
Items 201–300 of 300
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders
Helman, T. J., & Braidy, N. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00989-0 · Cited by 15
“In a preclinical study investigating the impact of NR supplementation in prediabetic and type 2 diabetic mice [103], NR provided improvements in fasting glucose levels and glucose tolerance of PD mice and mitigated dysmetabolic traits including hepatic steatosis, hypercholesterolemia, liver damage and weight gain.”
BackgroundZhang, J., & Chen, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116701 · Cited by 16
Calorie restriction mimetics against aging and inflammation
Chaudhary, S., Chaudhary, M. R., Jena, M. K., Rath, P. K., Mishra, B. P., Paital, B., Vyas, A., Sahoo, D. K., Singh, P., & Mehdi, M. M. (2025) · Biogerontology · doi:10.1007/s10522-025-10269-0 · Cited by 15
Metcalfe, M., David, B. T., Langley, B. C., & Hill, C. E. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114479 · Cited by 12
The emerging importance of NAD+ metabolome for nutrition and food sciences: A bibliometric analysis
Alegre, G. F. S., & Pastore, G. M. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103126 · Cited by 10
Dong, H., Guo, W., Yue, R., Sun, X., & Zhou, Z. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.100329 · Cited by 10
Bonet, M. L., Ribot, J., Sánchez, J., Palou, A., & Picó, C. (2024) · Cells · doi:10.3390/cells13100870 · Cited by 12
“VA, primarily as RA, modulates key aspects of adipocyte and AT biology, including adipogenic differentiation (adipogenesis), hypertrophic expansion, the capacity for fat oxidation and thermogenesis, and the secretory function, with possible benefits in the context of controlling body fat, obesity…”
BackgroundBerven, H., Svensen, M., Eikeland, H., Tvedten, N., Sheard, E., Geijerstam, S. A. A., Søgnen, M., McCann, A., Arnsten, L., Arseth, O., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114764 · Cited by 11
Pinker, S. A., & Ullman, M. T. (2002) · Cited by 9
Hamity, M. V., Kolker, S. J., Hegarty, D. M., Blum, C., Langmack, L., Aicher, S. A., & Hammond, D. L. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.1.38 · Cited by 8
NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice
Chandrasekaran, K., Najimi, N., Sagi, A. R., Yarlagadda, S., Salimian, M., Arvas, M. I., Hedayat, A. F., Kevas, Y., Kadakia, A., Kristián, T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021102 · Cited by 9
Nicotinamide riboside alleviates sweeteners-induced brain and cognitive impairments in immature mice
Jiang, Y., Zhang, H., Shi, J., Shan, T., Liu, M., Wang, P., Liang, X., & Liang, H. (2025) · Food & Function · doi:10.1039/d4fo05553e · Cited by 7
Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
Cercillieux, A., Ratajczak, J., Joffraud, M., Sanchez-Garcia, J. L., Jacot, G. E., Zollinger, A., Métairon, S., Giroud‐Gerbetant, J., Rumpler, M., Ciarlo, E., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101605 · Cited by 10
The Role of NAD+ and NAD+-Boosting Therapies in Inflammatory Response by IL-13
Pugel, A. D., Schoenfeld, A. M., Alsaifi, S. Z., Holmes, J. R., & Morrison, B. E. (2024) · Pharmaceuticals · doi:10.3390/ph17020226 · Cited by 7
“Increasing NAD + levels resulted in improved non-fasting glucose levels and glucose tolerance, normalized HbA1c, and reduced weight gain in these mice [5].”
BackgroundCosta, C. J., Cohen, M. W., Goldberg, D. C., Mellado, W., & Willis, D. E. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07913-5 · Cited by 8
“In fact, NR is currently in clinical trials as a disease-modifying therapy for diabetic neuropathy [25].”
BackgroundComment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”
Brenner, C. (2021) · Science · doi:10.1126/science.abj1696 · Cited by 7
“In a mouse model of diabesity, hepatic liver NAD phosphate (NADP) and reduced NADP (NADPH) were strikingly depressed and the hepatic NAD metabolome was rescued by oral provision of nicotinamide riboside (NR) in a manner that lowered hepatic steatosis and circulation of liver enzymes, protected against weight gain, imp…”
BackgroundSelf-citationLoss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease
Iqbal, T., Nawaz, A., Karim, M., Yaku, K., Hikosaka, K., Matsumoto, M., & Nakagawa, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.072 · Cited by 7
Hawkins, J., Idoine, R., Kwon, J., Shao, A. E., Dunne, E., Hawkins, E. M., Dawson, K., & Nkrumah-Elie, Y. M. (2024) · medRxiv · doi:10.1101/2024.06.06.24308565 · Cited by 9
The Crucial Role of NAD+ in Mitochondrial Metabolic Regulation
Mishra, K., & Kakhlon, O. (2025) · Biocell · doi:10.32604/biocell.2025.061725 · Cited by 8
“In mice with type 2 diabetes, NR demonstrated protective effects on the nervous system by enhancing glucose metabolism, decreasing weight gain and liver fat accumulation, and preventing nerve damage [83].”
Zeng, X., Wang, Y., Farias, K., Rappa, A., Darko, C., Sauve, A. A., Huang, Q., Alonso, L. C., & Yang, Y. J. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156110 · Cited by 6
Fluharty, N. T., & Brenner, C. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa109 · Cited by 7
“glycemic control itself could potentially reduce neuropathy (2), NR provides resistance to chemotherapeutic neuropathy that has been clearly shown to have targets in the nerve”
BackgroundInfluentialSelf-citationYuan, C., Yang, H., Lan, W., Yang, J., & Tang, Y. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12475 · Cited by 6
“NR has been shown to play an important role in insulin sensi‑ tivity and liver health (34,35).”
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
Acklin, S., Sadhukhan, R., Du, W., Patra, M., Cholia, R. P., & Xia, F. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac101 · Cited by 6
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
Yang, Y., Huang, J., Xie, L., Wang, Y., Guo, S., Wang, M., Shao, X., Liu, W., Wang, Y., Li, Q., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03721-7 · Cited by 5
“NR has been reported to prevent and alleviate glucose intolerance in insulin resistant models [12, 13].”
BackgroundDietary supplementation with nicotinamide riboside improves fetal growth under hypoglycemia
Lee, S. R., Jeong, S. H., Mukae, M., Kim, S.-Y., Ko, J., Kwun, H., & Hong, E. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109310 · Cited by 6
NAMPT/NAD+/PARP1 Pathway Regulates CFA‐Induced Inflammatory Pain via NF‐κB Signaling in Rodents
Dai, Y., Lin, J., Chen, X., Ren, J., Wu, C., Shen, H., Li, X., Yu, J., Jiang, B., & Yu, L. (2024) · Advanced Biology · doi:10.1002/adbi.202400028 · Cited by 5
Nicotinamide riboside Induced Energy Stress and Metabolic Reprogramming in BEAS-2B Cells
Cordeiro, E. W. F., Marzola, E. L., Maekawa, R. S., dos Santos, M. R., Assunção, L. G., Massafera, M. P., de Oliveira, J., Batista, T. G. C., de Sales, M. C. O. P., Maria–Engler, S. S., et al. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00312 · Cited by 7
Wahba, N. S., Abdel-Ghany, R. H., Ghareib, S. A., Abdel‐Aal, M., Alsemeh, A. E., & Sabry, D. (2021) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12721 · Cited by 6
“The intracellular NAD levels declined with obesity in various murine tissues [76].”
BackgroundRetractedHarnessing NAD+ Metabolism as Therapy for Cardiometabolic Diseases
Chakraborty, A. D., Minor, K., Nizami, H. L., Chiao, Y. A., & Lee, C. F. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00550-5 · Cited by 6
Enhancing NAD+ Metabolome in Cardiovascular Diseases: Promises and Considerations
Jahan, F., & Bagchi, R. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.716989 · Cited by 5
“NAD boosting was also shown to be beneficial for type 2 diabetes and diabetic neuropathy in mice (21).”
BackgroundBrenner, C. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519869679 · Cited by 5
Self-citationHe, C., Sun, X., Xu, T., Hu, X., Han, J., Xu, K., Song, Q., Duan, T., & Yang, J. J. (2025) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2025.503885 · Cited by 4
Bala, C. G., Rusu, A., Ciobanu, D. M., Román, G., & Craciun, A. E. (2025) · Metabolites · doi:10.3390/metabo15020086 · Cited by 5
Li, Y., Sun, S., Li, B., Li, Y., Liu, C., & Ta, D. (2025) · Ultrasonics · doi:10.1016/j.ultras.2025.107618 · Cited by 6
Sauve, A. A. (2022) · mSystems · doi:10.1128/msystems.01223-21 · Cited by 4
“These findings with NR administration have been reproduced by other researchers, and metabolic improvements have been observed in other mouse models of metabolic syndrome (10, 11).”
BackgroundAlegre, G. F. S., & Pastore, G. M. (2025) · CyTA - Journal of Food · doi:10.1080/19476337.2025.2458753 · Cited by 4
“…the abundance of NAD+ with precursor compounds, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), has promising effects on physiological function in many animal models of aging and diseases (Diguet et al., 2018; Huang et al., 2022; Mills et al., 2016; Trammell et al., 2016).”
Fernández‐Quintela, A., Santos, E. P. L., Portolés, T., Gual‐Grau, A., Sancho, J. V., & Portillo, M. P. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70078 · Cited by 2
Thirunavukarasu, J., Begam, R., & Shajahan, A. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.06.048 · Cited by 3
Letting off electrons to cope with metabolic stress
Heer, C. D., & Brenner, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0207-8 · Cited by 3
Self-citationBushana, P. N., Schmidt, M. A., Rempe, M. J., Sorg, B. A., & Wisor, J. P. (2023) · SLEEP Advances · doi:10.1093/sleepadvances/zpad044 · Cited by 4
“Several studies show that NR can attenuate weight gain on high-fat diets [20, 21] through alterations in body composition [22].”
BackgroundLi, Y., Zhang, C., Li, Z., Bai, F., Jing, Y., Ke, H., Zhang, S., Yan, Y., & Yu, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020082 · Cited by 3
“In mice models, NR increased NAD + metabolism, which improved glucose tolerance, reduced weight gain, and exhibited neuroprotective effects against diabetic neuropathy and hepatic steatosis [45].”
BackgroundNicotinamide Coenzymes and Metabolic Diseases
Lu, T., Qin, Z., & Wu, J. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_27 · Cited by 2
Mechanisms of NAD+ Homeostasis in Aging and Disease
McReynolds, M. R. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-112525-013335 · Cited by 2
Srinivas, T., Hanumaiah, G., Nagendra, D., Rao, S., Chaudhuri, S., Bhat, V. R., & Kamath, S. U. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08585-1 · Cited by 2
“Current evidence supporting NAD + repletion using precursors such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) remains predominantly preclinical [20, 67].”
Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging
Wang, F., Pei, Z., Wang, K., & Wang, L. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220304121917 · Cited by 3
Sauter, R., Sharma, S. A., & Heiland, I. (2024) · Biomolecules · doi:10.3390/biom14050602 · Cited by 2
Strategies for the prevention or reversal of neuropathy
Zilliox, L. A., Chandrasekaran, K., & Russell, J. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820669-0.00016-5 · Cited by 2
Molecular physiological studies on health effects of dietary nicotinamide riboside, a vitamin B3
Shi, W. (2019) · doi:10.18174/471911 · Cited by 2
Escalante‐Covarrubias, Q., Mendoza-Viveros, L., González-Suárez, M., Becerril-Pérez, F., Pacheco-Bernal, I., Carreño‐Vázquez, E., Sanchez, P. B. M., Bustamante-Zepeda, M., Orozco-Solís, R., & Aguilar‐Arnal, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.12.503453 · Cited by 2
Vitamin abnormalities in neuropathic corneal pain
Chow, B. J., Yu, M., Liu, C., Lee, I. X. Y., Tong, L. H. T., & Liu, Y. (2025) · Eye and Vision · doi:10.1186/s40662-025-00457-x · Cited by 1
“Oral nicotinamide riboside supplementation at a dose of 3 g/kg of diet in prediabetic rats has been shown to reduce thermal hypoalgesia, restore impaired nerve conduction velocity, and prevent corneal nerve degeneration [32].”
Gao, G.-F., Jiao, Y., & Sui-yi, L. I. U. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i34.111732 · Cited by 1
“The direct interference of the virus on NAMPT expression is believed to be mediated by the induction of miRNA expression, thereby inhibiting the translation of NAMPT[15,16], The possible mechanism involves the upregulation of MARylating PARPs, which induces the gene expression of enzymes responsible for NAD synthesis…”
Thomas, S., Ben-Davies, R., Cetinkaya‐Fisgin, A., Hu, X., Li, X., Stewart, S., Pan, B., Twiss, J. L., Ratan, R. R., Willis, D. E., et al. (2026) · Journal of the Peripheral Nervous System · doi:10.1111/jns.70101 · Cited by 1
“Studies in mice demonstrated that boosting NAD + levels can prevent neurotox-icity of paclitaxel [7] and cisplatin [8] as well as the development of polyneuropathy in high-fat diet fed mice [9, 10].”
Zeng, S., Tao, Y., & Guo, H. (2026) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10601 · Cited by 1
“Studies have demonstrated that NAD levels decline with age and in various disease states, including CKD and DN, contributing to exacerbated renal damage and impaired renal function [15 – 17].”
Metabolic Mechanisms in Diabetic Neuropathy
Yorek, M. A. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_15 · Cited by 1
Self-citationAnalysis of NAD and NAD-Dependent Protein Deacetylation in Mouse Tissues
Solovjeva, L., Панченко, А. В., Shabalin, K. A., Nerinovski, K., Yakimov, A., Александровна, Г. Е., Svetlova, M., Mudrak, O., Khodorkovskiy, M., Nikiforov, A. A., et al. (2018) · Cell and Tissue Biology · doi:10.1134/s1990519x18060123 · Cited by 1
Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
Teijeiro, A., & Djouder, N. (2017) · Oncoscience · doi:10.18632/oncoscience.338 · Cited by 1
Diabetic Neuropathy – Research
Chandrasekaran, K., Zilliox, L. A., & Russell, J. W. (2020) · Wiley eBooks · doi:10.1002/9781119309642.ch10 · Cited by 2
Voth, L. S., O’Connor, J. J., Kerr, C. M., Doerger, E., Schwarting, N., Sperstad, P. D., Johnson, D. K., & Fehr, A. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.30.437796 · Cited by 1
“PARP inhibitors significantly enhance the replication of MHV D1329A, while boosting the PARP substrate NAD+ with nicotinamide riboside further inhibits D1329A replication The D1329 residue is known to be critical for ADP-ribose binding from multiple studies (28, 29), however it is also conceivable that this mutation c…”
BackgroundInfluentialConnell, N. J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210122nc · Cited by 1
Long-Term NMN Treatment Increases Lifespan and Healthspan in Mice in a Sex Dependent MannerPreprint
Kane, A. E., Chellappa, K., S, M., Arnold, M. W., Li, J., Amorim, J. A., Diener, C., Zhu, D., Mitchell, S. J., Griffin, P. T., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4857461 · Cited by 3
Vitamin B3 salvage and NAD\(^+\) metabolism in skeletal muscle
Fletcher, R. S. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Katsyuba, E., & Auwerx, J. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00003-4
Yeo, D. (2020) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Skeletal muscle health in aging: a focus on mitochondria, metabolism and physical performance
Grevendonk, L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211006lg
Human brown adipose tissue: metabolic effects and clinical implications
Moonen, M. P. B. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210511mm
Imai, S. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726835440.793584719
GERENCIAMENTO HOSPITALAR E O IMPACTO NAS AÇÕES DE ENFERMAGEM
Costa, D. E., & Elias, L. S. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001764
REDUÇÃO DE DANOS: UM OLHAR INTEGRADO A PARTIR DA CLIENTELA, PROFISSIONAIS E GESTORES
Ximenes, A. F. C., Macêdo, C. C., Silva, L. P. S., Leite, L. R., Macêdo, M. E. C., Caldas, M. T., Ximenes, S. F. C., & Ueta, V. L. R. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001765
Pinto, M. C., de Gonçalves, F. F., Castanheira, C. R., & Ferreira, K. A. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001763
ANÁLISE DA EFETIVIDADE DA FISIOTERAPIA ATRAVÉS DA PSICOMOTRICIDADE EM IDOSOS INSTITUCIONALIZADOS
Banzatto, S., Alves, A. G. R. C., da Silva, C. M., Viana, M. D. O., Freitas, I. M. P., & de Menezes, J. N. R. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001768
Merlo, B. F. C., da Silva, E. H. O., Merlo, V. F. C., Abreu, C. B., de Oliveira, S. K., da Costa, J. C., Medeiros, F. B., & Gonçalves, C. O. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001758
FOOD RESTRICTION PROTECTS THE MYENTERIC NERVOUS POPULATION OF RATS WITH TYPE 2 DIABETES MELLITUS
da Rosa, C. V. D., de Campos, J. M., Goularte, G. S., de Godoi, V. A. F., & Natali, M. R. M. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001759
VALIAÇÃO DOS TRANSTORNOS ALIMENTARES NOS ESTUDANTES DE MEDICINA DA UNAERP NO PERÍDO DE 2021 A 2022
Canteri, N. C., & Rodrigues, J. N. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001769
Pereira, L. M., Silva, M. C., Trevisan, D. D. S., Neto, E. N. B., Gasparini, L. F. N., Moniwa, M., Silva, M. D. S. B., & Garcia, P. V. F. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001778
Alves, V. M. L., Reichert, J. T., Barbosa, K. L., Trindade, L. R., Lopes, P. S., Reis, S. G. R., Sanches, T. F., & Gramacho, Y. A. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001766
IMPACTOS E IMPLICAÇÕES DOS ACIDENTES POR QUEDAS NA QUALIDADE DE VIDA DOS IDOSOS
Conceição, A. C., Fantin, G., COSTA, G. V. E., Alovisi, G. L., Oliveira, I. C., AZEVEDO, L. A. D., Antunes, L. F., & dos Santos, T. D. S. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001773
JARDINS VERTICAIS COMO UMA PROPOSTA DE AMBIENTE AGRADÁVEL E DE BAIXO CUSTO EM ESCOLAS PÚBLICAS
Santos, I. I. D., Oliveira, G. G. D. S., Silva, K. K. B. D., Reitz, R. K., & de Souza, M. B. N. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001777
RELAÇÃO DA ESPIRITUALIDADE NO TRATAMENTO DE PACIENTES COM DOENÇA RENAL CRÔNICA
Kimura, C. K., Oliveira, I. C., Machado, M. C. D. A., & Pinto, L. G. T. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001761
DESENVOLVIMENTO DE MODELO ANIMAL DE DOENÇA HEPÁTICA GORDUROSA NÃO ALCOÓLICA: EXPERIMENTO PILOTO
Mota, J. A. S., de Oliveira, P. G. M., Dlugosz, A. C., Hessman, J. H., Karas, B., Calixto, C. M., Busnello, L. A., & Sturzeneker, M. C. S. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001789
Damgaard, M. V., Jepsen, S. L., Ashcroft, S. P., Holst, J. J., & Treebak, J. T. (2022) · Nutrients · doi:10.3390/nu14183741
“The initial dosage was 75 mg/kg and the follow up dosage was 50 mg/kg in accordance with a previous study that produced the desired phenotype [20].”
MethodResolving Geroplasticity to the Balance of Rejuvenins and Geriatrins
TABIBZADEH, S. S. (2022) · Aging and Disease · doi:10.14336/ad.2022.0414
“Similarly, NR improves glucose tolerance, and in models of diabetes and high-fat diet, improves metabolic function, prevents obesity, and reduces fat deposition [455, 476-479].”
BackgroundMetabolic precursors of nicotinamide adenine dinucleotide and the potential for their clinical use
Sutsko, I. P., Shlyahtun, A. H., & Semenenya, I. N. (2022) · Medical academic journal · doi:10.17816/maj89964
Obrosov, A. A., Coppey, L. J., Shevalye, H., & Yorek, M. A. (2022) · PubMed
Self-citationZeng, X., Wang, Y., Farias, K., Rappa, A., Darko, C., Sauve, A. A., & Yang, Y. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.29.610289
Zavyah, O. K., Bolboli, L., Siahkuhian, M., & Baghaiee, B. (2024) · Studies in Medical Sciences · doi:10.61186/umj.35.6.502
Strategies to Overcome Metabolic Syndrome and Related Diseases
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5556-9
The Application of Nicotinamide Coenzyme Precursors in Health Food
Feng, Z.-Y., She, J., Qin, Z., & Sheng, R. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_47
Olatomide, O. D., Musa, S. A., Bauchi, Z. M., Sambo, S. J., Agbon, A. N., Omoniyi, A. A., & Abolaji, A. O. (2025) · Research Square · doi:10.21203/rs.3.rs-7474241/v1
Palluth, L., Takahashi, J. S., & Green, C. B. (2025) · Life Metabolism · doi:10.1093/lifemeta/loaf034 · Cited by 5
“Further, this study argued that supplementation with NR, which ameliorates some of the negative metabolic effects of HFD, is likely working via increasing the NADP(H) pool rather than NAD(H) [131].”
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594448
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594445
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594451
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594454
Albahadly, W. K. Y., Rasool, M. I., Al-Saedi, H. F. S., Al-Kareem, Z. A., Hasan, S. A., Sahib, M. A., & Altrufi, M. H. (2026) · Cells · doi:10.3390/cells15161436 · Cited by 1
“…study may therefore represent a key https://doi.org/10.3390/cells15161436 molecular mechanism underlying the protective effects of NR against cisplatin-induced hepatorenal injury [38], consistent with the broader pharmacokinetic and metabolic properties of NR described above [29,33,34,39,40].”
InfluentialLysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins
Trivedi, K., & Dolinsky, V. W. (2026) · Pharmaceuticals · doi:10.3390/ph19101557
“In a model of HFD and low-dose STZ induced diabetes, NR supplementation (3 g of NR chloride per kg of HFD food) improved glucose tolerance, reduced hepatic steatosis and protected against diabetic peripheral neuropathy [193].”
Jiang, S., Liao, B., 王桂平, Sheng, R., Han, C., Jiang, Z., Pan, S., Wu, C., Liang, G., Zhu, Y., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06257-1
“Furthermore, NAD + has been shown to inhibit neuroinflammation associated with diabetes [35].”
Mitochondrial dysfunction in diabetic neuropathy: a core pathogenic hub and therapeutic implications
Wu, X., Li, X., Lou, N.-J., 庄向华, & Chen, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-09015-y
“In diabetic models, SARM1 gene knockout or inhibition of abnormal SARM1 activation both alleviate neuropathic damage [20, 126, 148, 149].”
InfluentialBindingDB (2025) · UC San Diego · doi:10.7270/q25x2fk7
Zhang, Y., Wu, Y., Wei, Y., Liu, X., Lei, X., Huang, H., & Li, M. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72465
Metadata
- Authors
- Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Iowa City VA Health Care System (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-27
- Volume
- 6
- Issue
- 1
- Pages
- 26933-26933
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4882590
- OpenAlex
- W2400466055
- Cited by
- 301
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 55 · 2021: 42 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 20 · 2016: 4
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01 BX001680, BX001680-01, BX001680, RX000889, C9251-C, RX000889-01, I01 RX000889)
- Roy J. Carver Charitable Trust
- Fraternal Order of Eagles
- National Institutes of Health (BX001680)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Institute of General Medical Sciences (T32GM008629)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081147)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide riboside, type 2 diabetes, diabetic neuropathy, NAD+ metabolism, insulin resistance, high-fat diet, streptozotocin-induced diabetes, hepatic steatosis, glucose tolerance, sensory neuropathy, corneal confocal microscopy, NADPH, neuroprotection, obesity
- MeSH terms
- Animals, Blood Glucose, Cornea, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Niacinamide, Obesity, Prediabetic State, Pyridinium Compounds, Streptozocin, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.